Le Lézard
Classified in: Health, Science and technology, Business
Subjects: MAV, ECO, POL

Media Advisory - The Economic Club of Canada: The Life Sciences Industry of Tomorrow: Healthy Canadians, Healthy Future


OTTAWA, Oct. 30, 2017 /CNW/ - What is the true contribution of the innovative pharmaceutical industry to the Canadian economy and R&D investment? What are the potential impacts of federal policy changes aimed at lowering drug prices? Is there a middle ground where Canada is able to lower prices while still retaining its position as a top tier destination for clinical trials and the launch of new innovative medicines? Innovative Medicines Canada President Pamela Fralick and panelists will discuss the results of a Fall 2017 analysis by Ernst & Young about industry's contributions to Canada and how industry and government can work together to enhance affordable, equitable and timely access to new therapies.

The event will be broadcast live over the internet at http://collaboratevideo.net/imc-mnc

Innovative Medicines Canada President Pamela Fralick will be available for media interviews after the event.

 

WHO:

Speakers

Pamela C. Fralick: President ? Innovative Medicines Canada

Moderator
Connie Côté, Chief Executive Officer, Health Charities Coalition of Canada

Panelists
Dr. Bill Cameron, Senior Scientist, Division of Infectious Diseases and Respirology, Medical Director, Clinical Research, Ottawa Hospital Research Institute
Ed Dybka, President and CEO ? AstraZeneca Canada Inc.

WHEN:

Tuesday, October 31, 2017 (11:30am-1:30pm)

11:15 am

Registration begins


12:15 pm

Opening remarks begin


12:25 pm

Keynote speech begin


12:40 pm

Panel

1:10 pm

Q&A

1:30 pm

Event concludes

WHERE:

Fairmont Chateau Laurier
1 Rideau Street, Ottawa
Drawing Room

 

About Innovative Medicines Canada

Innovative Medicines Canada is the national voice of Canada's innovative pharmaceutical industry. We advocate for policies that enable the discovery, development and commercialization of innovative medicines and vaccines that improve the lives of all Canadians. We support our members' commitment to being valued partners in the Canadian healthcare system.

 

SOURCE Innovative Medicines Canada


These press releases may also interest you

at 15:30
Roblox Corporation Sued for Securities Law Violations - Contact the Rosen Law Firm before August 12, 2024 to Discuss Your Rights - RBLX
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Roblox Corporation between November 15, 2023 and May 8, 2024, both dates inclusive (the "Class Period"), of the important August 12, 2024 lead plaintiff...

at 14:50
AESO Board Announcement: Leadership Transition and Departure of Michael Law
The Alberta Electric System Operator (AESO) Board announced today that Michael Law, President and Chief Executive Officer, will leave the organization, effective August 1, 2024. Law first joined the AESO in 2009 as Vice-President, Operations and was...

at 14:19
Hamilton ETFs Opens the Market
Jennifer Mersereau, Senior Partner, Co-Founder & COO, Hamilton ETFs, Patrick Sommerville, Senior Partner, Head of Business Development, Hamilton ETFs, and their team joined Keith Wu, Head, Exchange Traded Products, Toronto Stock Exchange , to open...

at 14:03
Maximizing Efficiency and Innovation in Food & Beverage Manufacturing Through Exponential IT Transformation: New Research From Info-Tech Research Group
New research insights from Info-Tech Tech Research Group will equip food and beverage manufacturers with essential strategies for embracing digital transformation. The global research and advisory firm explains that the industry can significantly...

at 13:50
Canadian General Investments: Investment Update - Unaudited
Canadian General Investments, Limited (CGI)  (LSE: CGI) reports on an unaudited basis that its net asset value per share (NAV) at June 30, 2024 was $62.50, resulting in year-to-date and 12-month NAV returns, with dividends reinvested, of 13.3% and...

at 13:40
Participation in Special Olympics Linked to Reduced Risk of Diabetes Among Individuals With Intellectual and Developmental Disabilities
New research led by the Faculty of Health Sciences at Ontario Tech University and published in Diabetic Medicine, reveals participation in Special Olympics programming is associated with a significantly lower risk of diabetes among adults with...

More news about Business...


News published on and distributed by: